Skip Navigation

European Heart Journal 2002 23(7):586; doi:10.1053/euhj.2001.3118
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Plewan, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Plewan, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

A reply

A. Plewan

German Heart Center and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

References

  1. Plewan A, Lehmann G, Ndrepepa G. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation: sotalol vs bisoprolol. Eur Heart J. 2001;22:1504–1510[Abstract/Free Full Text]
  2. Wanless RS, Anderson K, Joy M, Joseph SP. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrythmias. Am Heart J. 1997;133:441–446[CrossRef][Web of Science][Medline]
  3. Benditt DG, Williams JH, Jim J. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or flutter. D,l-Sotalol Atrial Fibrillation/Flutter Group. Am J Cardiol. 1999;84:270–277[CrossRef][Web of Science][Medline]
  4. Roden RM. Risks and benefits of antiarrhythmic therapy. N Engl J Med. 1994;331:785–791[Free Full Text]
  5. Steeds RP, Birchall AS, Smith M, Channer KS. An open label, randomized, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. Heart. 1999;82:170–175[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Plewan, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Plewan, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?